FundedIQ
Biotechnology

NLC: Funding, Investors & Team (Sep 2026)

NLC is a European venture builder in the health technology sector that specializes in bringing scientific health tech innovations to fruition. Their unique approach enables them to identify and develop inventions, as well as provide support to ventures with the potential to benefit patients. NLC was established in 2014 by Bert-Arjan Millenaar, its CEO and founder.

nlc.health LinkedIn Amsterdam, Netherlands 101-250 employees
Biopharma Health Care Health Diagnostics Innovation Management Medical Medical Device mHealth Personal Health
Total raised
$6.5M
Rounds
1
Latest
Undisclosed round
Jun 2024

NLC has raised $6.5M across 1 funding round on record, the most recent an undisclosed round of $6.5M announced in Jun 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

NLC Company Profile and Key Stats

Total funding raised
$6.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$6.5M in Jun 2024
Employees
101-250
reported band
Headquarters
Amsterdam, Netherlands

Latest funding round on record: Jun 2024.

NLC Funding Rounds

Date
Round
Amount
Undisclosed round
$6.5M

NLC Founders and Leadership Team

Name
Role
Contact
Bert Arjan Millenaar
Founder

No contact details are on record for this team yet.

NLC Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
740
$5.0M

NLC's latest round of $6.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like NLC in Biotechnology and Amsterdam

Companies Similar to NLC

The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…

Series B $20.5M

Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…

Undisclosed round $45.4M

Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…

Undisclosed round $47.8M

Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…

Undisclosed round

Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…

Series B $28.3M

Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…

Undisclosed round $300M

Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…

Series B $60.0M

We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…

Undisclosed round $5.7M

QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.

Pre-Seed $2.4M

Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…

Undisclosed round $1.1M

QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…

Undisclosed round $2.6M

BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…

Seed $3.1M

NLC Funding FAQs

What does NLC do?

NLC is a European venture builder in the health technology sector that specializes in bringing scientific health tech innovations to fruition. Their unique approach enables them to identify and develop inventions, as well as provide support to ventures with the potential to benefit patients. NLC was established in 2014 by Bert-Arjan Millenaar, its CEO and founder.

How much funding has NLC raised?

NLC has raised $6.5M across 1 round on record. The most recent is an undisclosed round of $6.5M announced in Jun 2024.

When did NLC last raise funding?

NLC's most recent funding round on record is an undisclosed round of $6.5M, announced in Jun 2024.

Who founded NLC?

FundedIQ lists Bert Arjan Millenaar (Founder) at NLC.

Where is NLC headquartered?

NLC is based in Amsterdam, Noord-Holland, Netherlands.

How many employees does NLC have?

NLC is in the 101-250 employee band.

How does NLC's funding compare to other Biotechnology startups?

NLC's latest round of $6.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's NLC Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NLC is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.